Minireviews
Copyright ©The Author(s) 2022.
World J Crit Care Med. Nov 9, 2022; 11(6): 349-363
Published online Nov 9, 2022. doi: 10.5492/wjccm.v11.i6.349
Table 3 Non randomized studies of vitamin C in sepsis
No.
Title
Ref.
Country of origin
Study design
Sample size in control arm
Sample size in intervention arm
Intervention summary
Results in brief
Studies using isolated vitamin C
1High dose intravenous vitamin C treatment in Sepsis: associations with acute kidney injury and mortalityMcCune et al[35], 2021United StatesCohort study (retrospective cohort)1178212Cohort of patients who have received at least one dose of 1.5 g IV vitamin CVitamin C therapy was associated with significant chances of AKI and death.
2Effect of high-dose intravenous vitamin C on point-of-care blood glucose level in septic patients: a retrospective, single-center, observational case seriesHe et al[38], 2020ChinaObservational case series82Patients with septic shock on admission received 100 mg/kg/d, while other patients received < 100 mg/kg/dHigh-dose vitamin C therapy may interfere with point-of-care glucose testing results.
3Pharmacokinetic data support 6-hourly dosing of intravenous vitamin C to critically ill patients with septic shockHudson EP et al[36], 2019AustraliaObservational PK study11Patients received 1.5 g intravenous vitamin C every 6 hInjectable vitamin C 1.5 g every 6 h helps in correction of vitamin C deficiency and hypovitaminosis C, and it also provides appropriate dosing schedule for vitamin C supplementation in septic shock.
4Accuracy of Point-of-Care Blood Glucose Level Measurements in Critically Ill Patients with Sepsis Receiving High-Dose Intravenous Vitamin CSmith et al[37], 2018United StatesObservational PK study5Patients who have received vitamin C 1500 mg intravenously two or more doses and had point of care blood glucose checked and laboratory venous BG levels measured within 1 h of each other during vitamin C therapyThe accuracy and agreement of POC BG did not have significant interreference during vitamin C treatment in sepsis.
5Phase I safety trial of intravenous ascorbic acid in patients with severe sepsisFowler et al[39], 2014United StatesPhase I safety trial24 total in 1:1:1 ratioPatients with severe sepsis in the medical intensive care unit were randomized 1:1:1 to receive intravenous infusions every 6 h for 4 d of ascorbic acid: Lo-AscA (50 mg/kg/24 h, n = 8), or Hi-AscA (200 mg/kg/24 h, n = 8), or placebo (5% dextrose/water, n = 8)Intravenous vitamin C infusion is safe and tolerated well and may have a positive impact on endothelial injury, the extent of multiple organ failure, and levels of inflammatory biomarkers.
Studies using combination therapies including vitamin C
6Adding vitamin C to hydrocortisone lacks benefit in septic shock: a historical cohort studyChang et al[40], 2020CanadaCohort study (retrospective cohort)8852Retrospective cohorts of vitamin C with hydrocortisone and hydrocortisone therapies for 72 h were compared in patients with sepsis or septic shockOutcomes for hospital mortality, ICU mortality, ventilator free days, vasopressor free days, dialysis use, and duration of ICU admission were comparable between the groups.
7Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After StudyMarik et al[22], 2017United StatesCohort study (before and after study)4747Intravenous vitamin C (1.5 g q6h for 4 d or until ICU discharge), hydrocortisone (50 mg q6h for 7 d or until ICU discharge followed by a taper over 3 d) as well as intravenous thiamine (200 mg q12h for 4 d or until ICU discharge)Results of this study suggest that the early use of intravenous vitamin C, together with corticosteroids and thiamine, prevents progressive organ dysfunction, including acute kidney injury, and reduces the mortality of patients with severe sepsis and septic shock.
Other studies
9Plasma Cortisol, Aldosterone, and Ascorbic Acid Concentrations in Patients with Septic Shock Do Not Predict Treatment Effect of Hydrocortisone on Mortality. A Nested Cohort StudyCohen et al[42], 2020Australia and NZCohort Study (nested cohort study)Levels of total and free plasma cortisol and aldosterone were measured along with quantitatively measured vitamin C levelsIn patients with septic shock, plasma aldosterone and ascorbic acid concentrations are not associated with outcome.
10Vitamin C levels amongst initial survivors of out of hospital cardiac arrestGardner et al[43], 2020United StatesObservational study3425 post arrest, 25 post sepsisObservationalVitamin C levels are lower in cardiac arrest patients in comparison to healthy patients.
11Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakesCarr et al[8], 2017New ZealandObservational study2024Patients with septic shock and non-septic aetiology Critically sick patients have low levels of vitamin C, and septic shock patients have significantly depleted levels.
12Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort StudyDalfino et al[41], 2015ItalyCohort (prospective cohort)39 non AKI31 AKIIntervention cohort patients have received colistin at a median daily dose of 9 million IUIndependent renal-protective role emerged for ascorbic acid among other factors responsible for higher chances of AKI.